SL
IRWD icon

Savior LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Savior LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-333
Closed -$4K – 478
2021
Q2 		$4K Hold
333
– – ﹤0.01% 619
2021
Q1 		$4K Hold
333
– – ﹤0.01% 632
2020
Q4 		$4K Hold
333
– – ﹤0.01% 611
2020
Q3 		$3K Hold
333
– – ﹤0.01% 635
2020
Q2 		$3K Hold
333
– – ﹤0.01% 582
2020
Q1 		$3K Hold
333
– – ﹤0.01% 557
2019
Q4 		$4K Buy
+333
New +$3.67K 0.01% 632

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Savior LLC's IRWD Position: Q3 2021 in Review

Savior LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2021, closing a stake of 333 shares — an estimated $4K sold.

Savior LLC first reported a position in IRWD in Q4 2019 and held it in 7 quarters. The position peaked at $4K in Q2 2021. 227 funds tracked by Wall St. Rank hold IRWD as of Q3 2021.

  • Savior LLC reported no remaining Ironwood Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 333 Ironwood Pharmaceuticals shares in Q3 2021, an estimated $4K.
  • Savior LLC first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Ironwood Pharmaceuticals position peaked at $4K in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.